- Services & Solutions
- Clients & Partners
Director, Discovery Technologies
Peter Madrid, Ph.D., focuses on developing broad-spectrum antibiotics, and on improved treatment regimens for tuberculosis. He leads multiple drug discovery programs at SRI.
Madrid has numerous research papers published in the field of anti-infectives drug discovery.
He received his Ph.D. in chemistry and chemical biology from the University of California, San Francisco, and his B.S. in chemistry from the University of California, Santa Cruz.